High altitude illness (HAI) occurs in the unique environment of hypobaric hypoxia and is generally thought to be due to hypoxia. A recent sheep study by Levine suggested that hypobaria and hypoxia together, but neither alone, produced a protein-rich pulmonary vascular leak, which is similar to high altitude pulmonary edema (HAPE). Many investigators have shown that hypoxia alone does not produce a high protein edema. Decades of clinical observations suggest that descent is more effective than oxygen for treatment of high altitude illness, also pointing to a possible role for hypobaria in addition to hypoxia. We hypothesize that decreased barometric pressure exerts an effect on capillary fluid dynamics which in combination with hypoxia produces vascular leak. As the first step in answering this question, we propose to compare oxygen and pressurization for treatment of HAI to document whether descent is truly superior to oxygen therapy. More rapid recovery from HAI with pressurization, compared to supplying the same PI02 by oxygen therapy, would be evidence for a role of hypobaria per se in the pathogenesis of high altitude illness. To answer these questions climbers ill with acute mountain sickness or HAPE will receive either hyperbaric therapy in a small, portable pressure chamber for six hours duration, or oxygen therapy at the same PI02 as the hyperbaric studies for the same duration. Changes in intravascular fluid volume and gas exchange will be studied. Alveolar PI02, alveolar PC02, arterial blood gases and pH, arterial oxygen saturation, fluid intake and output, electrocardiogram, respiratory rate, hemoglobin and hematocrit and signs and symptoms of HAI will be monitored throughout hyperbaric and oxygen therapy. This preliminary study may suggest mechanisms by which hypobaria per se contributes to HAI and indicate directions for further research into the pathogenesis of illness associated with hypobaric hypoxia. This question is important for all persons ascending to high altitude, for those in hypobaric environments such as during space travel, and perhaps for all hypoxic patients as well.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15HL040476-01
Application #
3440039
Study Section
Respiratory and Applied Physiology Study Section (RAP)
Project Start
1988-08-05
Project End
1989-08-04
Budget Start
1988-08-05
Budget End
1989-08-04
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Alaska Anchorage
Department
Type
Schools of Nursing
DUNS #
City
Anchorage
State
AK
Country
United States
Zip Code
99514